Importance of global communication to combat global pandemics: Lessons from the HIV Online Provider Education programme

Por Efeose A. Airewele, Henry Sunpath, Mahomed-Yunus S. Moosa, Rajesh T. Gandhi
Publicado em 2021-08-01

Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment Interruption

Por You Park, Behzad Etemad, Hayat Ahmed, Vivek Naranbhai, Evgenia Aga, Ronald J. Bosch, John W. Mellors, Daniel R. Kuritzkes, Michael Para, Rajesh T. Gandhi, Mary Carrington, Jonathan Z. Li
Publicado em 2017-11-01

Fully differentiated HIV-1 specific CD8+ T effector cells are more frequently detectable in controlled than in progressive HIV-1 infection.

Por Marylyn M Addo, Rika Draenert, Almas Rathod, Cori L Verrill, Benjamin T Davis, Rajesh T Gandhi, Gregory K Robbins, Nesli O Basgoz, David R Stone, Daniel E Cohen, Mary N Johnston, Theresa Flynn, Alysse G Wurcel, Eric S Rosenberg, Marcus Altfeld, Bruce D Walker
Publicado em 2007-03-01

The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial.

Por Rajesh T Gandhi, Lu Zheng, Ronald J Bosch, Ellen S Chan, David M Margolis, Sarah Read, Beatrice Kallungal, Sarah Palmer, Kathy Medvik, Michael M Lederman, Nadia Alatrakchi, Jeffrey M Jacobson, Ann Wiegand, Mary Kearney, John M Coffin, John W Mellors, Joseph J Eron, AIDS Clinical Trials Group A5244 team
Publicado em 2010-08-01